Clinical Trial Update: Pilot Study: The Role of Macrophage Migration Inhibitory Factor (MIF) in Spinal Cord Injury

View source ↗

Summary

An update on a pilot clinical trial assessing the role of macrophage migration inhibitory factor (MIF) in spinal cord injury. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Macrophage Migration Inhibitory Factor (Macrophage Migration Inhibitory Factor)

Snippet

Sponsor: Northwell Health | Conditions: Spinal Cord Injury | Status: COMPLETED